AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Marker Therapeutics, Inc. Director's Dealing 2012

Apr 20, 2012

35150_dirs_2012-04-20_53d0b62f-f9c3-4046-8e7e-afd788878f17.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TAPIMMUNE INC (TPIV)
CIK: 0001094038
Period of Report: 2012-02-17

Reporting Person: Reddish Mark (Vice President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166667	Direct